Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136.8 EUR | +0.35% |
|
-1.23% | -3.46% |
06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |